Tearlab Research Inc is categorized under Ultrasonic Scanning Devices, Medical in San Diego, CA and active since 2003.
Tearlab Research Inc was established in 2003, and today employs 1 to 4, earning Unknown per year. This is a Ultrasonic Scanning Devices, Medical business, which does work in the B2B market, and is classified as a Ultrasonic Scanning Devices, Medical, under code number 334510 by the NAICS.
If you are seeking more information, feel free to contact Elias Vamvakas at the company’s single location by writing to 9980 Huennekens St # 100, San Diego, California CA 92121 or by phoning No number given. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Tearlab Research Inc |
| Contact Person: | Elias Vamvakas |
| Address: | 9980 Huennekens St # 100, San Diego, California 92121 |
| Website Address: | tearlab.com |
| Annual Revenue (USD): | Unknown |
| Founded: | 2003 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Ultrasonic Scanning Devices, Medical |
| SIC Code: | 3845 |
| NAICS Code: | 334510 |
| Share This Business: |
Tearlab Research Inc was started in 2003 to provide professional Ultrasonic Scanning Devices, Medical under the SIC code 3845 and NAICS code 334510. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Elias Vamvakas for inquiries that concern Tearlab Research Inc by calling the company number No number given, as your correspondence is most welcome. Additionally, the physical location of the single location of Tearlab Research Inc can be found at the coordinates 32.9027,-117.179984 as well as the street address 9980 Huennekens St # 100 in San Diego, California 92121.
For its online presence, you may visit Tearlab Research Inc’s website at tearlab.com and engage with its social media outlets through on Twitter and on Facebook.